Air Force Tells Airmen to Stay Away From CBD Products

November 26, 2019 09:00:06

Cannabidiol (CBD) has been having an amazing run over the past few years. For an ingredient that was almost unknown a decade ago, CBD has quickly captured the minds and hearts of people around the globe. Said to have potent medicinal properties, the cannabis extract is used to manage a variety of conditions ranging from anxiety and high blood pressure to chronic pain.

However, despite the immense popularity cannabidiol has garnered, the industry is still heavily unregulated. Without a comprehensive regulatory structure, the market has been flooded with a plethora of sellers, each selling products promising untold medical benefits. Due to this, numerous institutions have shied away from using CBD, and the U.S. Air Force is the latest to register…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.